Evidence map›Paper›PMID 38459218›Full record

ReviewAging clinical and experimental research2024

Medication review and deprescribing in different healthcare settings: a position statement from an Italian scientific consortium.

Massimo Carollo, Virginia Boccardi, Salvatore Crisafulli, Valeria Conti, Paola Gnerre, Simonetta Miozzo, Emanuela Omodeo Salè, Fabio Pieraccini, Mauro Zamboni, Alessandra Marengoni and 3 more

Open access · hybridAbstract readReviewConsensus Statement
PubMed Full text at PMC Publisher
In one paragraph

Review in Aging clinical and experimental research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 1 country.

Massimo CarolloDepartment of Diagnostics and Public Health, University of Verona, P.Le L.A. Scuro 10, 37124, Verona, Italy.ORCID http://orcid.org/0000-0002-6523-6036
Virginia BoccardiInstitute of Gerontology and Geriatrics, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.ORCID http://orcid.org/0000-0003-2134-1122
Salvatore CrisafulliDepartment of Diagnostics and Public Health, University of Verona, P.Le L.A. Scuro 10, 37124, Verona, Italy.ORCID http://orcid.org/0000-0001-6625-1943
Valeria ContiClinical Pharmacology Unit, Department of Medicine, Surgery and Dentistry, University of Salerno, Salerno, Italy.ORCID http://orcid.org/0000-0001-6964-2739
Paola GnerreLigure 2 Local Health Unit, Savona, Italy.ORCID http://orcid.org/0000-0002-1397-6059
Simonetta MiozzoItalian Society of General Medicine and Primary Care, Florence, Italy.
Emanuela Omodeo SalèDivision of Pharmacy, IEO European Institute of Oncology IRCCS, Milan, Italy.ORCID http://orcid.org/0000-0002-7641-8708
Fabio PieracciniRomagna Local Health Unit, Pharmacy Unit, Forlì-Cesena, Italy.
Mauro ZamboniDepartment of Medicine-Geriatric Division, University of Verona, Verona, Italy.ORCID http://orcid.org/0000-0001-6961-9483
Alessandra MarengoniDepartment of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.ORCID http://orcid.org/0000-0002-4851-1825
Graziano OnderUniversità Cattolica del Sacro Cuore, Rome, Italy.ORCID http://orcid.org/0000-0003-3400-4491
Gianluca TrifiròDepartment of Diagnostics and Public Health, University of Verona, P.Le L.A. Scuro 10, 37124, Verona, Italy. gianluca.trifiro@univr.it.ORCID http://orcid.org/0000-0003-1147-7296
Italian Scientific Consortium on medication review, deprescribing
University of Verona · ITCentro Cardiologico Monzino · ITAzienda Sanitaria Locale N. 2 Savonese · ITAzienda Unità Sanitaria Locale Della Romagna · ITSocietà Italiana di Medicina Generale · ITUniversità Cattolica del Sacro Cuore · ITUniversity of Brescia · ITUniversity of Perugia · ITUniversity of Salerno · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent medical advancements have increased life expectancy, leading to a surge in patients affected by multiple chronic diseases and consequent polypharmacy, especially among older adults. This scenario increases the risk of drug interactions and adverse drug reactions, highlighting the need for medication review and deprescribing to reduce inappropriate medications and optimize therapeutic regimens, with the ultimate goal to improving patients' health and quality of life. This position statement from the Italian Scientific Consortium on medication review and deprescribing aims to describe key elements, strategies, tools, timing, and healthcare professionals to be involved, for the implementation of medication review and deprescribing in different healthcare settings (i.e., primary care, hospital, long-term care facilities, and palliative care). Challenges and potential solutions for the implementation of medication review and deprescribing are also discussed.

Indexed as

DeprescriptionsAgedHumansInappropriate PrescribingItalyMedication ReviewPolypharmacyQuality of LifeDeprescribingFrailtyMedication reviewMultimorbidityPatient-centered carePolypharmacy

Identifiers

PMID38459218
PMCPMC10923734
OpenAlexW4392601244

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.